Tag: Promising
-
Wave Life Sciences Reports Promising Phase 1 Results for WVE-007: Significant Body Composition Improvement in Obesity Patients
Wave Life Sciences USA, Inc. Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% reduction in total body fat (3.5 lbs; p=0.07), and a 3.2% increase in lean mass (4.0 lbs; p=0.01), with no statistically…
-
Clascoterone 5% Achieves Promising Phase 3 Hair Growth Outcomes
Cosmo Pharmaceuticals has reported encouraging topline findings from 2 large, identically designed phase 3 trials evaluating clascoterone 5% topical solution for male androgenetic alopecia (AGA). If ultimately approved, the drug could represent the first new therapeutic mechanism for AGA in over 30 years—a notable development for a condition with high prevalence and limited treatment options.1…